These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Proceedings: Effects of perhexiline maleate in angina pectoris: a double-blind clinical evaluation with ECG-treadmill exercise testing. Morledge J Postgrad Med J; 1973 Apr; 49():Suppl 3:64-7. PubMed ID: 4587034 [No Abstract] [Full Text] [Related]
47. [Clinical trial by perexiline maleate in treatment of angina pectoris (author's transl)]. Corsini G; Correale E; Oriani G; Persico S; Tritto C G Ital Cardiol; 1975; 5(1):73-86. PubMed ID: 1120556 [TBL] [Abstract][Full Text] [Related]
48. Clinical inhibition of CYP2D6-catalysed metabolism by the antianginal agent perhexiline. Davies BJ; Coller JK; James HM; Gillis D; Somogyi AA; Horowitz JD; Morris RG; Sallustio BC Br J Clin Pharmacol; 2004 Apr; 57(4):456-63. PubMed ID: 15025744 [TBL] [Abstract][Full Text] [Related]
49. Warner oration. Advances in drug therapy of angina pectoris, with special reference to perhexiline maleate. Datey KK; Dalvi CP Indian Heart J; 1974 Jan; 26(1):1-5. PubMed ID: 4608031 [No Abstract] [Full Text] [Related]
50. Modulation of myocardial metabolism: an emerging therapeutic principle. Horowitz JD; Chirkov YY; Kennedy JA; Sverdlov AL Curr Opin Cardiol; 2010 Jul; 25(4):329-34. PubMed ID: 20535068 [TBL] [Abstract][Full Text] [Related]
51. Report of a multicentre monitored release study of perhexiline maleate in the prevention of angina pectoris. Lockhart JD; Masheter HC Br J Clin Pract; 1976 Sep; 30(9):172-7. PubMed ID: 826264 [No Abstract] [Full Text] [Related]
52. [2 new anti-angina drugs: amiodarone and perhexiline maleate. Advantages and adverse effects]. Rullière R; Bickert P Rev Prat; 1976 Dec; 26(59):4251-6. PubMed ID: 1006108 [No Abstract] [Full Text] [Related]
53. Can Perhexiline Be Utilized Without Long-Term Toxicity? A Clinical Practice Audit. Phuong H; Choi BY; Chong CR; Raman B; Horowitz JD Ther Drug Monit; 2016 Feb; 38(1):73-8. PubMed ID: 26309031 [TBL] [Abstract][Full Text] [Related]
55. [Perhexiline maleate in the treatment of angina pectoris]. Forattini C; Perin S Minerva Cardioangiol; 1976 Apr; 24(4):308-15. PubMed ID: 792717 [No Abstract] [Full Text] [Related]
56. [Clinical study of a new anti-angina agent: perhexiline maleate]. Linquette M; Mesmacque R; Benoit G Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1313-5. PubMed ID: 4802930 [No Abstract] [Full Text] [Related]
58. [Effects of perhexiline maleate in angina pectoris: preliminary clinical and experimental results of a comparative study]. Caponnetto S; Iannetti M; Pastorini C; Masperone MA; Perugini P Boll Soc Ital Cardiol; 1975; 20(11):1433-7. PubMed ID: 791305 [No Abstract] [Full Text] [Related]
59. A new approach to the evaluation of anti-anginal drugs (with special reference to Perhexiline maleate). Datey KK; Dalvi CP Indian Heart J; 1973 Jan; 25(1):3-8. PubMed ID: 4576303 [No Abstract] [Full Text] [Related]
60. Effects of perhexiline maleate on coronary flow distribution in the ischemic canine myocardium. Klassen GA; Sestier F; L'Abbate A; Mildenberger RR; Zborowska-Sluis DT Circulation; 1976 Jul; 54(1):14-20. PubMed ID: 1277417 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]